Welcome to Continuing Professional Development for Nurses

	CONTACT ABOUT HELP NEWS LOG IN INTERNATIONAL Email address Password Forgot password?
	References for Gastritis and the proton pump inhibitors Do you want to complete this activity to gain 2 hours of continuing professional development? National Institute for Health and Care Excellence. (2014). Dyspepsia and gastro-oesophageal reflux disease: investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both. Accessed January 2019. https://www.nice.org.uk/guidance/cg184/evidence/full-guideline-pdf-193203757 Gustafson, J. & Welling, D. (2010). “No acid, no ulcer” – 100 years later: a review of the history of peptic ulcer disease. Journal of the American College of Surgeons.210(1): 110-116. Malfertheiner, P., Kandulski, A. & Venerito, M. (2017). Proton-pump inhibitors: understanding the complications and risks. Nature Reviews: Gastroenterology & Hepatology. 14: 697-710. Statista. (2018). Leading chemical drugs dispensed in England in 2017. Accessed February 2019. https://www.statista.com/statistics/378445/prescription-cost-analysis-top-twenty-chemicals-by-items-in-england/ Marks, D. (2016). Time to halt overprescribing of proton pump inhibitors. The Pharmaceutical Journal. 8(8): DOI: 10.1211/CP.2016.20201548 NPS Medicinewise. (2018). StePPIng the appropriate path with GORD medicines. Accessed January 2019. https://cdn0.scrvt.com/08ab3606b0b7a8ea53fd0b40b1c44f86/46d8899849570192/388367b654ea/MW_News_PPIs_for_GORD_2018_v2.pdf Keung, C. & Hebbard, G. (2016). The management of gastro-oesophageal reflux disease. Australian Prescriber. 39: 36-39. Hunt, R. et al. (2015). The stomach in health and disease. Gut. 64(10): 1650-1668. BPAC (2014). Gastro-oesophageal reflux disease and its complications. Best practice Journal. 61. Accessed January 2019. https://bpac.org.nz/bpj/2014/june/gord.aspx Wehbi, M. (2017). Acute gastritis. Medscape Reference. Accessed January 2019. https://emedicine.medscape.com/article/175909-overview Rang et al. (2016). Rang and Dale’s Pharmacology. (8^th edition). London: Churchill Livingstone. NPS Medicinewise (2015). Proton pump inhibitors: too much of a good thing? Accessed February 2019. https://www.nps.org.au/news/proton-pump-inhibitors-too-much-of-a-good-thing Gracie, D. & Ford, A. (2016). The possible risks of proton pump inhibitors. Medical Journal of Australia.205(7): 292-293. Marshall B. (2016). A Brief History of the Discovery of Helicobacter pylori. In: Suzuki H., Warren R., Marshall B. (eds) Helicobacter pylori. Springer, Tokyo CREATE ACCOUNT FIND ARTICLES TAKE THE TOUR Make a new account to start learning online. Create account Search the list of articles. Find articles Learn about the site and how it can help you. Take the tour	LATEST ARTICLES Show all MR-SID: Medication-Related Substance Impaired Driving Delirium - often overlooked Asthma Understanding diuretics NSAIDS: risks and benefits Gastritis and the proton pump inhibitors LATEST NEWS Can drugs cause dementia? Link Influenza Vaccine: Calling the shots Link Medicinal cannabis: all smoke? Link Is your Christmas ham killing you? Link

	CONTACT HELP SHARE: FACEBOOK TWITTER

CONTACT ABOUT HELP NEWS LOG IN INTERNATIONAL

CONTINUING PROFESSIONAL DEVELOPMENT FOR NURSES

References for Gastritis and the proton pump inhibitors

National Institute for Health and Care Excellence. (2014). Dyspepsia and gastro-oesophageal reflux disease: investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both. Accessed January 2019. https://www.nice.org.uk/guidance/cg184/evidence/full-guideline-pdf-193203757
Gustafson, J. & Welling, D. (2010). “No acid, no ulcer” – 100 years later: a review of the history of peptic ulcer disease. Journal of the American College of Surgeons.210(1): 110-116.
Malfertheiner, P., Kandulski, A. & Venerito, M. (2017). Proton-pump inhibitors: understanding the complications and risks. Nature Reviews: Gastroenterology & Hepatology. 14: 697-710.
Statista. (2018). Leading chemical drugs dispensed in England in 2017. Accessed February 2019. https://www.statista.com/statistics/378445/prescription-cost-analysis-top-twenty-chemicals-by-items-in-england/
Marks, D. (2016). Time to halt overprescribing of proton pump inhibitors. The Pharmaceutical Journal. 8(8): DOI: 10.1211/CP.2016.20201548
NPS Medicinewise. (2018). StePPIng the appropriate path with GORD medicines. Accessed January 2019. https://cdn0.scrvt.com/08ab3606b0b7a8ea53fd0b40b1c44f86/46d8899849570192/388367b654ea/MW_News_PPIs_for_GORD_2018_v2.pdf
Keung, C. & Hebbard, G. (2016). The management of gastro-oesophageal reflux disease. Australian Prescriber. 39: 36-39.
Hunt, R. et al. (2015). The stomach in health and disease. Gut. 64(10): 1650-1668.
BPAC (2014). Gastro-oesophageal reflux disease and its complications. Best practice Journal. 61. Accessed January 2019. https://bpac.org.nz/bpj/2014/june/gord.aspx
Wehbi, M. (2017). Acute gastritis. Medscape Reference. Accessed January 2019. https://emedicine.medscape.com/article/175909-overview
Rang et al. (2016). Rang and Dale’s Pharmacology. (8^th edition). London: Churchill Livingstone.
NPS Medicinewise (2015). Proton pump inhibitors: too much of a good thing? Accessed February 2019. https://www.nps.org.au/news/proton-pump-inhibitors-too-much-of-a-good-thing
Gracie, D. & Ford, A. (2016). The possible risks of proton pump inhibitors. Medical Journal of Australia.205(7): 292-293.
Marshall B. (2016). A Brief History of the Discovery of Helicobacter pylori. In: Suzuki H., Warren R., Marshall B. (eds) Helicobacter pylori. Springer, Tokyo